Gambari, R.; Gamberini, M.R.; Cosenza, L.C.; Zuccato, C.; Finotti, A.
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic. J. Clin. Med. 2025, 14, 289.
https://doi.org/10.3390/jcm14010289
AMA Style
Gambari R, Gamberini MR, Cosenza LC, Zuccato C, Finotti A.
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic. Journal of Clinical Medicine. 2025; 14(1):289.
https://doi.org/10.3390/jcm14010289
Chicago/Turabian Style
Gambari, Roberto, Maria Rita Gamberini, Lucia Carmela Cosenza, Cristina Zuccato, and Alessia Finotti.
2025. "A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic" Journal of Clinical Medicine 14, no. 1: 289.
https://doi.org/10.3390/jcm14010289
APA Style
Gambari, R., Gamberini, M. R., Cosenza, L. C., Zuccato, C., & Finotti, A.
(2025). A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic. Journal of Clinical Medicine, 14(1), 289.
https://doi.org/10.3390/jcm14010289